In the first case of its kind, the Federal Trade Commission took action against a diet pill seller for both with fake positive reviews.
The fruit of garcinia cambogia has been hailed by some as a powerful weight loss supplement. It is, however, a rare indication that it may lead to liver failure, which has led to the FDA's publication of a product containing the active ingredient-which is why most purveyors of junk diet pills tend to make their efficacy claims vague. Cure Encapsulations, which the FTC ruled against yesterday, had no such modesty, instead of stating that the extract in question "Literally BLOCKS FAT From Forming."
What differentiates this from every other fake weight loss panacea fiasco is that Naftula Jacobowitz, the owner / operator of Cure Encapsulations, "paid a website, amazonverifiedreviews.com, to create and post Amazon reviews of their product," according to the FTC's claim to an average rating of 4.3 stars. As the world's largest ecommerce marketplace, Amazon has become the world's largest source for cutthroat tactics. They are trustworthy.
Unsurprisingly, Jacobowitz has previously succumbed to another researcher's submission for "false negative." Feedback and / or other false complaints to Amazon.com, "which the plaintiff claims caused to loose the coveted Amazon 'Buy Box,' a piece of real estate associated with higher sales.
Amazon itself has taken legal action over the years on multiple occasions against entities
Recommended in the ruling and pending judgment in New York's Eastern District Court, are a variety of stipulations against Jacobowitz's Cure Encapsulations. His company would be required to notify prior customers of the claims against it and identify the paid reviews for Amazon. The company would no longer be able to make "weight loss, appetite suppression, fat blocking, or disease treatment claims" fine of $ 12.8 million.